SETTLEMENT AGREEMENTSettlement Agreement • September 23rd, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
This Settlement Agreement (the “Agreement”) is made and entered into as of September 19, 2005 (the “Effective Date”), by and between Alliance Pharmaceutical Corp. (the “Alliance”) and Imcor Pharmaceutical Co. (formerly Photogen Technologies, Inc.) (“Imcor”). Alliance and Imcor may be referred to herein individually as a “Party” and together as the “Parties.”
SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • September 23rd, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New Jersey
This Settlement and License Agreement (“Agreement”) is effective and entered into as of September 19, 2005 (the “Effective Date”), by and between GE Healthcare Ltd. f/k/a Amersham plc, Amersham Health, Inc., and Amersham Health AS, (collectively “Amersham”), IMCOR Pharmaceutical Co. f/k/a Photogen Technologies, Inc. (“IMCOR”), Alliance Pharmaceutical Corp. (“Alliance”), and Molecular Biosystems, Inc. (“MBI”), (Amersham, IMCOR, Alliance, and MBI, collectively “the Parties”).
